Sector: MedicalAbbott Laboratories (NYSE: ABT)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 42 |
Technical : | 82 |
Performance : | 180 |
Overall: | 53 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 43 |
Technical : | 144 |
Performance : | 192 |
Overall: | 109 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 39 |
Technical : | 102 |
Performance : | 216 |
Overall: | 90 |
Number of Stocks: | 305 |
Headlines
- Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on the Value of Prostate Cancer Screening and Invites the American Cancer Society to Act Immediately
Nov 04, 2009 09:41 AM | ABT, DGX
- AGA Medical Receives Product Approvals in China
Nov 04, 2009 08:01 AM | ABT
- Coldstream Laboratories, Inc. Names Vice President
Nov 03, 2009 12:11 PM | ABT, BAX
- President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department
Nov 03, 2009 10:01 AM | ABT
- Abbott Saving 1 Billion Gallons of Water Annually
Nov 02, 2009 11:00 AM | ABT
- Abbott's XIENCE PRIME(TM) and XIENCE V(R) Receive Indications in Europe for Treatment of Patients with Diabetes
Nov 02, 2009 09:53 AM | ABT
- Abbott Completes Acquisition of Evalve, Inc.
Nov 02, 2009 08:02 AM | ABT
- Impax Laboratories Confirms Patent Challenge Relating to TRICOR(R) 48mg and 145mg Tablets
Oct 30, 2009 10:45 AM | ABT, IPXL
- Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
Oct 29, 2009 11:01 AM | ABT
- ICAP Ocean Tomo Engaged to Exclusively License Intellectual Property Portfolios from Lawrence Livermore National Laboratory on Behalf of Lawrence Livermore National Security, LLC
Oct 27, 2009 12:20 PM | ABT, GE, IBM, INTC, MSFT, PFE
- Beware, Many Stolen Computers Have Tracking Software
Oct 26, 2009 10:55 AM | ABT, BBY
- Boston Scientific returns to profit in 3rd qtr
Oct 19, 2009 07:52 PM | ABT, BSX, STJ
- Sliding Dollar May Be Something to Cheer About
Oct 16, 2009 01:51 PM | ABT, PG
- Abbott Reports Earnings Gain on Stronger Sales, Settlement of Patent Suit: W.W. Grainger Reports Revenue Continues to Fall
Oct 15, 2009 05:55 AM | ABT, ACAS, GWW, MDT
- Abbott Profit Up 37% on Patent Settlement, Humira Sales
Oct 14, 2009 03:11 PM | ABT, MDT
- Humira and nutrition sales lift Abbott 3Q profit
Oct 14, 2009 12:51 PM | ABT, JNJ
- St. Louis Post-Dispatch, David Nicklaus Column
Oct 04, 2009 03:56 PM | ABT, XRX
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 01:17 PM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 06:13 AM | ABT, CRXL, CSL, JNJ, PFE, SGP
- BosSci Paying $716M to J&J: Action Resolves Some, but Not All, Heart Stent Suits
Sep 30, 2009 04:13 AM | ABT, BSX, JNJ, MDT, WWY
- Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets
Oct 30, 2009 10:52 AM | ABT, IPXL
- Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
Oct 19, 2009 09:53 AM | ABT, CLRT, DGX, IART, PFE
- Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
Aug 27, 2009 09:01 AM | ABT
- Medtronic Reports First Quarter Revenue of $3.9 Billion
Aug 25, 2009 07:57 AM | ABT, MDT
- Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Aug 24, 2009 09:01 AM | ABT
- Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
Aug 18, 2009 09:01 AM | ABT
- StreetSmart Strategies®, a Management Consulting Firm, Retains Veteran Corporate Investor Relations Officer David Prichard
Aug 18, 2009 07:52 AM | ABT, BG, C, CPO, MOD
- Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Aug 13, 2009 09:01 AM | ABT
- Impax Laboratories Receives Final FDA Approval for Generic Depakote® Extended-Release 500mg Tablets
Aug 05, 2009 01:53 PM | ABT, IPXL
- Absolute Refutes Claims of BIOS Vulnerability
Jul 31, 2009 07:49 PM | ABT
- Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: ALBAN CARLOS (10K)
Nov 04, 2009 05:49 PM
- Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: Mason Heather L (10K)
Nov 04, 2009 05:47 PM
- Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Warmuth Michael J (10K)
Oct 22, 2009 06:50 PM
- Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Fussell Stephen R (10K)
Oct 22, 2009 06:49 PM
- Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: ROBERTS ROY S (10K)
Oct 22, 2009 06:48 PM
- Form 4 ABBOTT LABORATORIES For: Oct 16 Filed by: Patton Donald V JR (10K)
Oct 20, 2009 07:48 PM
- Form 4 ABBOTT LABORATORIES For: Oct 16 Filed by: Warmuth Michael J (10K)
Oct 20, 2009 07:46 PM
- Form 4 ABBOTT LABORATORIES For: Oct 15 Filed by: ALBAN CARLOS (10K)
Oct 19, 2009 07:00 PM
- Form 3 ABBOTT LABORATORIES For: Oct 15 Filed by: ALBAN CARLOS (10K)
Oct 19, 2009 06:55 PM
- Form 4 OSBORN WILLIAM A For: Sep 30 (10K)
Oct 02, 2009 05:49 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ABT
|
Compare to S&P
|
| YTD |
-5.25 %
|
-17.40 %
|
| 4 Weeks |
1.46 %
|
0.39 %
|
| 12 Weeks |
15.35 %
|
12.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 2.22 %
|
|
EPS Growth in Last Year: 16.46 %
|
|
Sales Growth in Last Quarter: 3.55 %
|
|
Sales Growth in Last Quarter: 3.51 %
|
|
